These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1982 related items for PubMed ID: 18845169
21. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Liu ZL, Hirano T, Tanaka S, Onda K, Oka K. J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364 [Abstract] [Full Text] [Related]
22. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo. Fang W, Li Y, Cai Y, Kang K, Yan F, Liu G, Huang W. J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326 [Abstract] [Full Text] [Related]
23. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux. Chavanpatil MD, Patil Y, Panyam J. Int J Pharm; 2006 Aug 31; 320(1-2):150-6. PubMed ID: 16713148 [Abstract] [Full Text] [Related]
24. Protein kinase C isoform expression and activity alter paclitaxel resistance in vitro. Chen L, Burger RA, Zaunbrecher GM, Cheng H, Lincoln AJ, Mallarino MC, Monk BJ, Khan SA. Gynecol Oncol; 1999 Feb 31; 72(2):171-9. PubMed ID: 10021296 [Abstract] [Full Text] [Related]
25. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Tang XQ, Bi H, Feng JQ, Cao JG. Acta Pharmacol Sin; 2005 Aug 31; 26(8):1009-16. PubMed ID: 16038636 [Abstract] [Full Text] [Related]
26. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux. Tainton KM, Smyth MJ, Jackson JT, Tanner JE, Cerruti L, Jane SM, Darcy PK, Johnstone RW. Cell Death Differ; 2004 Sep 31; 11(9):1028-37. PubMed ID: 15131592 [Abstract] [Full Text] [Related]
27. Drug resistance in chemotherapy for breast cancer. Saeki T, Tsuruo T, Sato W, Nishikawsa K. Cancer Chemother Pharmacol; 2005 Nov 31; 56 Suppl 1():84-9. PubMed ID: 16273361 [Abstract] [Full Text] [Related]
28. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ, Wu CH, Choi MR, Najafi F, Emami A, Safa AR. Biochem Pharmacol; 2006 Jul 28; 72(3):293-307. PubMed ID: 16753135 [Abstract] [Full Text] [Related]
29. Cytotoxic and multidrug resistance reversal activities of novel 1,4-dihydropyridines against human cancer cells. Shekari F, Sadeghpour H, Javidnia K, Saso L, Nazari F, Firuzi O, Miri R. Eur J Pharmacol; 2015 Jan 05; 746():233-44. PubMed ID: 25445037 [Abstract] [Full Text] [Related]
30. Stable suppression of MDR-1 gene using siRNA expression vector to reverse drug resistance in a human uterine sarcoma cell line. Hua J, Mutch DG, Herzog TJ. Gynecol Oncol; 2005 Jul 05; 98(1):31-8. PubMed ID: 15921732 [Abstract] [Full Text] [Related]
31. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Arora A, Seth K, Kalra N, Shukla Y. Toxicol Appl Pharmacol; 2005 Feb 01; 202(3):237-43. PubMed ID: 15667829 [Abstract] [Full Text] [Related]
32. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Jin J, Wang FP, Wei H, Liu G. Cancer Chemother Pharmacol; 2005 Feb 01; 55(2):179-88. PubMed ID: 15378274 [Abstract] [Full Text] [Related]
33. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol. Li L, Jiang AC, Dong P, Wang H, Xu W, Xu C. Ann Surg Oncol; 2009 May 01; 16(5):1421-8. PubMed ID: 19247716 [Abstract] [Full Text] [Related]
34. A new apoptosis inhibitor, CIAPIN1 (cytokine-induced apoptosis inhibitor 1), mediates multidrug resistance in leukemia cells by regulating MDR-1, Bcl-2, and Bax. Li X, Hong L, Zhao Y, Jin H, Fan R, Du R, Xia L, Luo G, Fan D. Biochem Cell Biol; 2007 Dec 01; 85(6):741-50. PubMed ID: 18059532 [Abstract] [Full Text] [Related]
35. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine. Gosland MP, Gillespie MN, Tsuboi CP, Tofiq S, Olson JW, Crooks PA, Aziz SM. Cancer Chemother Pharmacol; 1996 Dec 01; 37(6):593-600. PubMed ID: 8612315 [Abstract] [Full Text] [Related]
36. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin. Chang CC, Huang LH, Chiang W, Hsia SM. Phytomedicine; 2018 Aug 01; 47():69-80. PubMed ID: 30166110 [Abstract] [Full Text] [Related]
37. The effect of the plasticizer diethylhexyl phthalate on transport activity and expression of P-glycoprotein in parental and doxo-resistant human sarcoma cell lines. Angelini A, Centurione L, Sancilio S, Castellani ML, Conti P, Di Ilio C, Porreca E, Cuccurullo F, Di Pietro R. J Biol Regul Homeost Agents; 2011 Aug 01; 25(2):203-11. PubMed ID: 21880209 [Abstract] [Full Text] [Related]
38. Reversal effect of Tween-20 on multidrug resistance in tumor cells in vitro. Yang S, Liu J, Chen Y, Jiang J. Biomed Pharmacother; 2012 Apr 01; 66(3):187-94. PubMed ID: 22440896 [Abstract] [Full Text] [Related]
39. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Weerasinghe P, Hallock S, Tang SC, Trump B, Liepins A. Exp Toxicol Pathol; 2006 Aug 01; 58(1):21-30. PubMed ID: 16735106 [Abstract] [Full Text] [Related]
40. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Wang F, Zhang D, Zhang Q, Chen Y, Zheng D, Hao L, Duan C, Jia L, Liu G, Liu Y. Biomaterials; 2011 Dec 01; 32(35):9444-56. PubMed ID: 21903258 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]